Clinical trials are a cornerstone of cancer research. Before a trial can commence, it must receive approval from regulatory authorities and an Institutional Review Board (IRB). This involves submitting detailed protocols outlining the study's design, patient population, and safety measures. Regulatory bodies review these protocols to ensure ethical standards and participant safety.
